GenePeeks

Delve Bio presents study showing utility of metagenomic next generation sequencing (mNGS) in diagnosing neurological infections

Retrieved on: 
Wednesday, April 17, 2024
Research, Infectious Diseases, Neurology, Biotechnology, Other Health, Health, General Health, Other Science, Science, American Academy, GenePeeks, University, Cancer, Foundation Medicine, Genomics, DSM-IV codes, Infection, Bacteria, Fortune 500, Medical laboratory, Clear Labs, NGS, CLIA, Medicine, Encephalitis, UCSF, Ventricular septal defect, Patient, Meningitis, Parasitism, AAN, Physician, Immunodeficiency, Virus, Neuro, Fungus, CSF, Diagnosis, Neoplasm, Cerebrospinal fluid, Metagenomics, Pharmaceutical industry

The study included a large cohort of more than 4,800 patients over seven years diagnosed at UCSF.

Key Points: 
  • The study included a large cohort of more than 4,800 patients over seven years diagnosed at UCSF.
  • In addition, the study found mNGS provided a definitive diagnosis for nearly 1 in 3 immunocompromised patients.
  • Ultimately, Delve Neuro will enable more patients with potentially life-threatening neurological infections to benefit from faster, more comprehensive diagnoses.
  • Prior to joining Delve Bio, Mr. Field served as Chief Commercial Officer at Clear Labs and IDbyDNA (acquired by Illumina).

JUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM

Retrieved on: 
Tuesday, October 18, 2022
SAN, LinkedIn, Woman, Women's health, Sequenom, Phlebotomy, Patient, Collection, GenePeeks, Company, Marketing, Health, Genetic testing, NIPS, Pharmaceutical industry, Management, Invitae

SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Juno Diagnostics (JunoDx), a company focused on bringing vital health information to patients by improving access, affordability and transparency, today announced the addition of Gina Grayum to its commercial leadership team.

Key Points: 
  • SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Juno Diagnostics (JunoDx), a company focused on bringing vital health information to patients by improving access, affordability and transparency, today announced the addition of Gina Grayum to its commercial leadership team.
  • Ms. Grayum brings more than a decade of diagnostics sales and management experience to JunoDx, most recently as U.S.
  • "We are excited to welcome someone of Gina's caliber to the JunoDx leadership team.
  • Juno Diagnostics is a category defining health company bringing vital prenatal health information to patients by combining access, affordability and transparency.

LetsGetChecked Appoints Rebecca Silver as Senior Vice President of Marketing

Retrieved on: 
Tuesday, October 5, 2021
Technology, Audio, Video, Software, Practice Management, Other Health, Internet, Health, General Health, VoIP, Gynaecology, Thyroid, Brand, Pharmacy, GenePeeks, Health, Multimedia, Diabetes, CEO, Growth, Fertility, Founder, COVID-19, Silver, EU, VP, SVP, Reproductive health, Pharmaceutical industry

LetsGetChecked, a leading virtual care company, appoints Rebecca Silver as its new SVP of Marketing, effective immediately.

Key Points: 
  • LetsGetChecked, a leading virtual care company, appoints Rebecca Silver as its new SVP of Marketing, effective immediately.
  • Prior, she led marketing and business development at GenePeeks, a genetic screening and analytics company that was acquired after its Series B.
  • As our company enters its next phase of growth, theres no one better to lead our marketing efforts than Rebecca, commented Peter Foley, CEO and Founder of LetsGetChecked.
  • As SVP of Marketing, Silver will devise, orchestrate, and implement strategy and partnerships for LetsGetChecked and oversee its integrated marketing, creative, and communications teams.